Rothschild Investment LLC Stoke Therapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q4 2024
A detailed history of Rothschild Investment LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 50 shares of STOK stock, worth $534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 40
25.0%
Holding current value
$534
Previous $492,000
12.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding STOK
# of Institutions
131Shares Held
57.6MCall Options Held
9.3KPut Options Held
24.7K-
Skorpios Trust6.91MShares$73.8 Million99.8% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$57.8 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$55.4 Million22.22% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$54.7 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$49.5 Million0.57% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $421M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...